Akitoshi Kawamura
About
In The Last Decade
Akitoshi Kawamura
33 papers receiving 166 citations
Peers
Comparison fields: 5 of 55
- Computational Theory and Mathematics 65
- Oncology 51
- Infectious Diseases 36
- Epidemiology 24
- Artificial Intelligence 24
Countries citing papers authored by Akitoshi Kawamura
This map shows the geographic impact of Akitoshi Kawamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akitoshi Kawamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akitoshi Kawamura more than expected).
Fields of papers citing papers by Akitoshi Kawamura
This network shows the impact of papers produced by Akitoshi Kawamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akitoshi Kawamura. The network helps show where Akitoshi Kawamura may publish in the future.
Co-authorship network of co-authors of Akitoshi Kawamura
This figure shows the co-authorship network connecting the top 25 collaborators of Akitoshi Kawamura. A scholar is included among the top collaborators of Akitoshi Kawamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akitoshi Kawamura. Akitoshi Kawamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 18 | |
| 8 | 12 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 7 | |
| 12 | 1 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | Risk factors for nasopharyngeal carcinoma. | 15 |
| 16 | Histopathological and immunological studies of nasopharyngeal carcinoma. | 2 |
| 17 | Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody. | 8 |
| 18 | Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody. | 14 |
| 19 | High anti-EB virus titer in sera of patients with nasopharyngeal carcinoma: a small-scaled seroepidemiological study. | 10 |
| 20 | Diagnosis of influenza by means of fluorescent antibody technique. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.